Antisense oligonucleotide strategies in neuropharmacology
- 28 February 1994
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 15 (2) , 42-46
- https://doi.org/10.1016/0165-6147(94)90107-4
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Inhibition of axonal growth by SNAP-25 antisense oligonucleotides in vitro and in vivoNature, 1993
- Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctionsNature, 1993
- Astrogliosis in culture: I. The model and the effect of antisense oligonucleotides on glial fibrillary acidic protein synthesisJournal of Neuroscience Research, 1993
- Modulation of Anxiety and Neuropeptide Y-Y1 Receptors by Antisense OligodeoxynucleotidesScience, 1993
- Antisense oligonucleotide eliminates in vivo expression of c-fos in mammalian brainEuropean Journal of Pharmacology: Molecular Pharmacology, 1992
- Translational suppression of a glutamate receptor subunit impairs long‐term potentiationSynapse, 1992
- Translation inhibition by an mRNA coding region secondary structure is determined by its proximity to the AUG initiation codonJournal of Molecular Biology, 1992
- Suppression of kinesin expression in cultured hippocampal neurons using antisense oligonucleotides.The Journal of cell biology, 1992
- Therapeutic Applications of OligonucleotidesAnnual Review of Pharmacology and Toxicology, 1992
- Sequence-Selective Recognition of DNA by Strand Displacement with a Thymine-Substituted PolyamideScience, 1991